Clinical Microbiology Market is in trends driven by automation and digitalization

 The apparatus, reagents, and consumables used in laboratory diagnosis to detect infectious disorders make up the clinical microbiology market. Products for microbiological identification and evaluating antibiotic susceptibility, such as blood culture medium, Gram stain reagents, and culture media, are frequently utilized. Accurate laboratory testing is becoming more and more necessary due to the rising incidence of infectious diseases like HIV/AIDS, TB, malaria, and new pathogens.

 The global clinical microbiology market is estimated to be valued at US$ 7.19 Bn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period from 2024 to 2031.

Key players operating in the clinical microbiology market are Danaher, Abbott, Hologic, Inc., Bruker, Bio-Rad Laboratories, Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Analytik Jena GmbH+Co. KG, Biolab Scientific, Reichert, Inc. , BIOBASE GROUP, Cole-Parmer Instrument Company, LLC. , ESICO INTERNATIONAL, Isolab Laborgeräte GmbH, Eppendorf SE, Biosan, Beckman Coulter, Inc., NuAire, Inc.

Clinical Microbiology Market 
null

Key Takeaways

Key players: Key players in the Clinical Microbiology Market  are focused on introducing integrated automated systems, digital applications and molecular diagnostic platforms to streamline workflow and provide faster results. For instance, BioMerieux launched BioFire Diagnostic's PCR-based diagnostic panels and automated incubators to decentralize testing close to patients.

Growing demand: Rising prevalence of infectious diseases, growing geriatric population, increasing adoption of rapid diagnostics in hospitals and clinical laboratories are fueling demand for clinical microbiology products globally.

Global expansion: Key market players are expanding their geographic presence into emerging economies through partnerships, acquisitions and new product launches at competitive prices to tap into higher growth opportunities in Asia Pacific and Latin America.

Market key trends

One of the key trends in the clinical microbiology market is the shift towards automation and digitalization of workflow. Automated systems help streamline laboratory processes for culture, identification and antimicrobial susceptibility testing. Digital platforms enable connectivity of devices, remote diagnostics and artificial intelligence driven data analysis for optimized diagnosis and research. Increased adoption of automated and integrated systems is expected to drive clinical microbiology market growth over the forecast period.

Porter’s Analysis
Threat of new entrants: Low setup costs and global presence of large players creates barriers for new players.
Bargaining power of buyers: Large number of buyers with differentiated needs limits the bargaining power of individual buyers.
Bargaining power of suppliers: Established distribution channels and global supply chains limits the influence of individual suppliers.
Threat of new substitutes: Limited threat as clinical microbiology solutions are focused on specific diagnostic needs.
Competitive rivalry: Intense competition among major players to gain market share through product differentiation, service offerings and partnerships.

Geographical Regions
North America accounted for the major share of the global clinical microbiology market in 2019, primarily due to increasing research initiatives, global presence of key market players, availability of reimbursements and growing demand for accurate disease diagnosis and treatment monitoring in the region. Asia Pacific is anticipated to witness the highest growth during the forecast period, owing to increasing healthcare expenditures, growing disposable incomes, improving healthcare infrastructure and expansion strategies by key market players.

The clinical microbiology market in emerging countries is expected to witness the fastest growth during the forecast period. This can be attributed to growing investments by pharmaceutical companies, increasing demand for infectious disease diagnostics, developing healthcare infrastructure and rising medical tourism in these regions. Countries such as China, India, Brazil, Russia and South Africa are likely to become highly lucrative markets in the near future.

Comments

Post a Comment

Popular posts from this blog

Vegan Yogurt Market is Poised for Growth Driven by Rising Health Consciousness

Image
Vegan yogurt is a dairy-free alternative to conventional yogurt made from plant-based milk such as soy, almond, oat, coconut or rice. It provides similar texture and taste to dairy yogurt but without any animal products.Vegan yogurt offers several health advantages over dairy yogurt as it is devoid of lactose, cholesterol and saturated fats. The growing number of people adopting vegan and flexitarian diets has driven the demand for plant-based dairy alternatives like vegan yogurt. The global vegan yogurt market is estimated to be valued at US$ 4.15 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031. Key Takeaways Key players- Met Fods, Cocos Organic, Hain Celestial, EasiYo Product Limited, Danone, General Mills Inc., Stonyfield Far, Inc., Daiya Foods Inc.m Good Karma foods, Inc.m Hudson River Foodsm NANCY'S, Kite Hill, COYO Pty lTd., Nush Foods, Chobani, LLC, Barambah Oraganics Pty Ltd., Blue Diamond Growers, Dean Foodsm General Mills Inc
Read more

Hypoglycemic Drugs Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Diabetes in the Geriatric Population

Image
Hypoglycemic drugs or anti-diabetic drugs are medications used to treat diabetes mellitus by lowering blood glucose levels. Some key hypoglycemic drugs include insulin, sulfonylureas, metformin, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and GLP-1 receptor agonists. These drugs help control blood sugar levels in diabetics and prevent or delay diabetes-related health complications. The global hypoglycemic drugs market is estimated to be valued at US$ 720.72 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The growth of the global hypoglycemic drugs market is majorly driven by the increasing prevalence of diabetes in the geriatric population globally. As per estimates, around 1 in every 11 people aged 65 years and above have diabetes. Further, the number of people with diabetes in this age group is anticipated to grow from 25.9 million in 2017 to
Read more

Clinical Trials Rising with Digital Technologies Adoption

Image
 Clinical trials support services play a vital role in assisting sponsors and life science companies to conduct clinical trials in a precise and well-organized manner.These services assist pharmaceutical companies in patient recruitment, data management, site management, and overall clinical trial management. With rising complexities in clinical trials owing to integration of technologies like telehealth and remote patient monitoring, the demand for these support services is growing substantially. The global Clinical Trials Support Services Market is estimated to be valued at US$ 22.38 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The growing adoption of digital technologies across clinical trials is a key trend accelerating the growth of the clinical trials support services market. Digital tools like electronic data capture, clinical trial managemen
Read more